Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer. 2013

Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
Departments of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Androgen receptor (AR) signaling is critical for the tumorigenesis and development of prostate cancer, as well as the progression to castration-resistant prostate cancer. We previously showed that the heterochromatin protein 1 (HP1) β isoform plays a critical role in transactivation of AR signaling as an AR coactivator that promotes prostate cancer cell proliferation. However, the roles of other HP1 isoforms, HP1α and HP1γ, in AR expression and prostate cancer remain unclear. Here, we found that knockdown of HP1γ, but not HP1α, reduced AR expression and cell proliferation by inducing cell cycle arrest at G1 phase in LNCaP cells. Conversely, overexpression of full-length HP1α and its C-terminal deletion mutant increased AR expression and cell growth, whereas overexpression of HP1γ had no effect. Similarly, HP1α overexpression promoted 22Rv1 cell growth, whereas HP1γ knockdown reduced the proliferation of CxR cells, a castration-resistant LNCaP derivative. Taken together, HP1 isoforms distinctly augment AR signaling and cell growth in prostate cancer. Therefore, silencing of HP1β and HP1γ may be a promising therapeutic strategy for treatment of prostate cancer.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D002868 Chromosomal Proteins, Non-Histone Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. Non-Histone Chromosomal Proteins,Chromosomal Proteins, Non Histone,Chromosomal Proteins, Nonhistone,Non-Histone Chromosomal Phosphoproteins,Chromosomal Phosphoproteins, Non-Histone,Non Histone Chromosomal Phosphoproteins,Non Histone Chromosomal Proteins,Nonhistone Chromosomal Proteins,Proteins, Non-Histone Chromosomal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090266 Chromobox Protein Homolog 5 A protein located within beta-heterochromatin that is involved in suppression of POSITION EFFECT VARIEGATION. HP-1 Protein,Heterochromatin Protein 1,Heterochromatin-Specific Nonhistone Chromosomal Protein HP-1,HP 1 Protein
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020033 Protein Isoforms Different forms of a protein that may be produced from different GENES, or from the same gene by ALTERNATIVE SPLICING. Isoform,Isoforms,Protein Isoform,Protein Splice Variant,Splice Variants, Protein,Protein Splice Variants,Isoform, Protein,Isoforms, Protein,Splice Variant, Protein,Variant, Protein Splice,Variants, Protein Splice
D034741 RNA, Small Interfering Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions. RNA, Scan,Repeat-Associated siRNA,Scan RNA,Small Scan RNA,Trans-Acting siRNA,siRNA,siRNA, Repeat-Associated,siRNA, Trans-Acting,Short Hairpin RNA,Short Interfering RNA,Small Hairpin RNA,Small Interfering RNA,scnRNA,shRNA,tasiRNA,Hairpin RNA, Short,Hairpin RNA, Small,Interfering RNA, Short,Interfering RNA, Small,RNA, Short Hairpin,RNA, Short Interfering,RNA, Small Hairpin,RNA, Small Scan,Repeat Associated siRNA,Scan RNA, Small,Trans Acting siRNA,siRNA, Repeat Associated,siRNA, Trans Acting

Related Publications

Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
June 2010, Endocrine-related cancer,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
December 2000, Asian journal of andrology,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
November 2001, Journal of the National Cancer Institute,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
September 2014, Cancer metastasis reviews,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
October 2003, Zhonghua nan ke xue = National journal of andrology,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
January 2002, Zhonghua nan ke xue = National journal of andrology,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
October 2012, The Prostate,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
February 2010, International journal of oncology,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
May 2015, Oncotarget,
Momoe Itsumi, and Masaki Shiota, and Akira Yokomizo, and Eiji Kashiwagi, and Ario Takeuchi, and Katsunori Tatsugami, and Junichi Inokuchi, and Yoohyun Song, and Takeshi Uchiumi, and Seiji Naito
June 2011, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!